LUCD
Price
$1.02
Change
-$0.03 (-2.86%)
Updated
Nov 19 closing price
Capitalization
133.72M
130 days until earnings call
Intraday BUY SELL Signals
NXL
Price
$1.05
Change
-$0.01 (-0.94%)
Updated
Nov 19 closing price
Capitalization
18.92M
13 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LUCD vs NXL

Header iconLUCD vs NXL Comparison
Open Charts LUCD vs NXLBanner chart's image
Lucid Diagnostics
Price$1.02
Change-$0.03 (-2.86%)
Volume$523.89K
Capitalization133.72M
Nexalin Technology
Price$1.05
Change-$0.01 (-0.94%)
Volume$87.25K
Capitalization18.92M
LUCD vs NXL Comparison Chart in %
LUCD
Daily Signal:
Gain/Loss:
NXL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LUCD vs. NXL commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LUCD is a Hold and NXL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (LUCD: $1.02 vs. NXL: $1.04)
Brand notoriety: LUCD and NXL are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: LUCD: 52% vs. NXL: 2%
Market capitalization -- LUCD: $133.72M vs. NXL: $18.92M
LUCD [@Medical/Nursing Services] is valued at $133.72M. NXL’s [@Medical/Nursing Services] market capitalization is $18.92M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $219.36B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LUCD’s FA Score shows that 0 FA rating(s) are green whileNXL’s FA Score has 0 green FA rating(s).

  • LUCD’s FA Score: 0 green, 5 red.
  • NXL’s FA Score: 0 green, 5 red.
According to our system of comparison, LUCD is a better buy in the long-term than NXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LUCD’s TA Score shows that 5 TA indicator(s) are bullish while NXL’s TA Score has 4 bullish TA indicator(s).

  • LUCD’s TA Score: 5 bullish, 5 bearish.
  • NXL’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, LUCD is a better buy in the short-term than NXL.

Price Growth

LUCD (@Medical/Nursing Services) experienced а -8.11% price change this week, while NXL (@Medical/Nursing Services) price change was -17.46% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.47%. For the same industry, the average monthly price growth was -8.60%, and the average quarterly price growth was +8.79%.

Reported Earning Dates

LUCD is expected to report earnings on Mar 30, 2026.

NXL is expected to report earnings on Dec 03, 2025.

Industries' Descriptions

@Medical/Nursing Services (-5.47% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LUCD($134M) has a higher market cap than NXL($18.9M). LUCD YTD gains are higher at: 24.588 vs. NXL (-62.319). NXL has higher annual earnings (EBITDA): -9M vs. LUCD (-54.36M). LUCD has more cash in the bank: 31.1M vs. NXL (5.79M). NXL has less debt than LUCD: NXL (0) vs LUCD (27.6M). LUCD has higher revenues than NXL: LUCD (4.36M) vs NXL (175K).
LUCDNXLLUCD / NXL
Capitalization134M18.9M709%
EBITDA-54.36M-9M604%
Gain YTD24.588-62.319-39%
P/E RatioN/AN/A-
Revenue4.36M175K2,491%
Total Cash31.1M5.79M537%
Total Debt27.6M0-
TECHNICAL ANALYSIS
Technical Analysis
LUCDNXL
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 17 days ago
82%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LUCD
Daily Signal:
Gain/Loss:
NXL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ST28.83-0.01
-0.03%
Sensata Technologies Holding plc
VEEV273.00-0.72
-0.26%
Veeva Systems
INMD14.05-0.10
-0.71%
InMode Ltd
ROLR2.17-0.03
-1.36%
High Roller Technologies Inc
ARCT6.03-0.59
-8.91%
Arcturus Therapeutics Holdings

LUCD and

Correlation & Price change

A.I.dvisor tells us that LUCD and NOTV have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LUCD and NOTV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LUCD
1D Price
Change %
LUCD100%
-2.86%
NOTV - LUCD
32%
Poorly correlated
-4.13%
FEMY - LUCD
30%
Poorly correlated
+5.40%
NXL - LUCD
27%
Poorly correlated
-1.89%
CRL - LUCD
27%
Poorly correlated
-0.55%
INGN - LUCD
26%
Poorly correlated
-2.09%
More

NXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NXL has been loosely correlated with HYPR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if NXL jumps, then HYPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NXL
1D Price
Change %
NXL100%
-1.89%
HYPR - NXL
35%
Loosely correlated
-1.87%
NNOX - NXL
33%
Loosely correlated
-8.46%
CERS - NXL
31%
Poorly correlated
+1.34%
BFLY - NXL
31%
Poorly correlated
+19.40%
MYO - NXL
30%
Poorly correlated
+0.25%
More